Related Experiment Video
Updated: Aug 11, 2026

06:05
A BW Reporter System for Studying Receptor-Ligand Interactions
Published on: January 7, 2019
Reporter Gene Assay for Monitoring BCL6 Reactivation
Catherine L Ingram1, Radosław P Nowak2, Thomas M Geiger3
1Institute of Structural Biology, University of Bonn, Bonn, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|August 10, 2026
Summary
Researchers developed a new assay to measure the activity of the BCL6 transcription factor using a small molecule activator. This method, utilizing luciferase reporter gene technology, offers a versatile platform for studying transcription factor drug targets.
Area of Science:
- Molecular Biology
- Drug Discovery
- Epigenetics
Background:
- Transcription factors are key regulators of gene expression and emerging drug targets.
- Small molecule-induced proximity is a novel strategy to control transcription factor activity.
- BCL6 is a significant transcription factor implicated in various cellular processes.
Purpose of the Study:
- To develop and validate a transcriptional activity assay for the BCL6 transcription factor.
- To demonstrate the utility of small molecule activators in modulating transcription factor function.
- To establish a flexible assay adaptable for other transcription factors.
Main Methods:
- Development of a luciferase reporter assay system in HEK293T cells.
- Utilized transient transfection with BCL6-expressing and reporter plasmids.
- Employed a specific BCL6 DNA-binding sequence to control luciferase expression.
Main Results:
- Successfully established a functional assay to measure BCL6 transcriptional activity.
- Demonstrated the ability of the small molecule activator TCIP1 to modulate BCL6 activity.
- Validated the specificity of the assay for BCL6.
Conclusions:
- The developed assay provides a robust method for studying BCL6 activity.
- This platform enables the screening and characterization of small molecules targeting transcription factors.
- The assay's adaptability facilitates research into diverse transcription factor drug targets.

